Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Accumulated Expenses: 2013-2025

Historic Accumulated Expenses for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $121.1 million.

  • Phibro Animal Health's Accumulated Expenses rose 46.14% to $121.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.1 million, marking a year-over-year increase of 46.14%. This contributed to the annual value of $139.0 million for FY2025, which is 56.58% up from last year.
  • Phibro Animal Health's Accumulated Expenses amounted to $121.1 million in Q3 2025, which was down 12.89% from $139.0 million recorded in Q2 2025.
  • Over the past 5 years, Phibro Animal Health's Accumulated Expenses peaked at $139.0 million during Q2 2025, and registered a low of $68.7 million during Q3 2022.
  • Over the past 3 years, Phibro Animal Health's median Accumulated Expenses value was $82.9 million (recorded in 2024), while the average stood at $95.0 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first declined by 10.87% in 2021, then surged by 56.58% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Accumulated Expenses stood at $72.8 million in 2021, then dropped by 1.62% to $71.7 million in 2022, then increased by 5.05% to $75.3 million in 2023, then surged by 56.16% to $117.6 million in 2024, then soared by 46.14% to $121.1 million in 2025.
  • Its Accumulated Expenses stands at $121.1 million for Q3 2025, versus $139.0 million for Q2 2025 and $118.6 million for Q1 2025.